Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL

Modern Rheumatology

Volumn 22, Issue 4, 2012, Pages 541-549

  Furuya, Takumi ^a   Koga, Minori ^a   Hikami, Koki ^a   Kawasaki, Aya ^a   Tsuchiya, Naoyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Polymorphism; Splicing; Systemic lupus erythematosus; TNFSF13 (APRIL)

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; FURIN;

ALTERNATIVE RNA SPLICING; APRIL GENE; ARTICLE; CELL LYSATE; CONCENTRATION (PARAMETERS); DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; HAPLOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; HEK293 CELLS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; TRANSFECTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84865394431     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0539-z     Document Type: Article

References (27)

1. Hahne M, Kataoka T, Schröter M, Hofmann K, Irmler M, Bodmer JL, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med. 1998;188: 1185-90. (Pubitemid 28443341)
2. Kelly K, Manos E, Jensen G, Nadauld L, Jones DA. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 2000;60:1021-7. (Pubitemid 30129540)
3. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002; 3:822-9.
4. Dillon SR, Gross JA, Ansell SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov. 2006;5:235-46. (Pubitemid 43336036)
5. Koyama T, Tsukamoto H, Miyagi Y, Himeji D, Otsuka J, Miyagawa H, et al. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis. 2005;64:1065-7. (Pubitemid 40909524)
6. Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003;48:982-92. (Pubitemid 36418240)
7. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol. 2005;25:189-201. (Pubitemid 40884044)
8. Thangarajh M, Masterman T, Rot U, Duvefelt K, Brynedal B, Karrenbauer VD, et al. Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis. J Neuroimmunol. 2005;167:210-4. (Pubitemid 41242304)
9. Koyama T, Tsukamoto H, Masumoto K, Himeji D, Hayashi K, Harada M, et al. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology. 2003;42:980-5. (Pubitemid 37220967)
10. Kawasaki A, Tsuchiya N, Ohashi J, Murakami Y, Fukazawa T, Kusaoi M, et al. Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese. Rheumatology. 2007;46:776-82. (Pubitemid 47061707)
11. Lee YH, Ota F, Kim-Howard X, Kaufman KM, Nath SK. APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility. Rheumatology. 2007;46:1274-6. (Pubitemid 47244500)
12. Shu HB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol. 1999;65:680-3. (Pubitemid 29227061)
13. Zhang J, Roschke V, Baker KP, Wang Z, Alarcón GS, Fessler BJ, et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol. 2001;166:6-10. (Pubitemid 32038409)
14. Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, et al. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Rheumatology. 2007; 46:1083-6. (Pubitemid 47050608)
15. Davidson A. Targeting BAFF in autoimmunity. Curr Opin Immunol. 2010;22:732-9.
16. Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189:1747-56. (Pubitemid 29272691)
17. López-Fraga M, Fernández R, Albar JP, Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2001;2:945-51. (Pubitemid 33040585)
18. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000; 404:995-9. (Pubitemid 30243593)
19. Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol. 2000;1:252-6.
20. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001;293:2108-11. (Pubitemid 32848062)
21. Yan M, Brady JR, Chan B, Lee WP, Hsu B, Harless S, Cancro M, Grewal IS, Dixit VM. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol. 2001;11:1547-52. (Pubitemid 32931019)
22. Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner QG, Cachero TG, et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med. 2005;201:1375-83. (Pubitemid 40664082)
23. Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood. 2007;109:2961-7. (Pubitemid 46482094)
24. Tian S. A 20 residues motif delineates the furin cleavage site and its physical properties may influence viral fusion. Biochem Insights. 2009;2:9-20.
25. Gavin AL, Aït-Azzouzene D, Ware CF, Nemazee D. DBAFF, an alternate splice isoform regulates receptor binding biopresentation of B cell survival cytokine. J Biol Chem. 2003;278:38220-8. (Pubitemid 37221711)
26. Rennert P, Schneider P, Cachero TG, Thompson J, Trabach L, Hertig S, et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med. 2000;192:1677-84.
27. Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol. 2006;18: 263-75. (Pubitemid 44287558)